Soleus Capital Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-102,067
| Closed | -$4.48M | – | 96 |
|
|
2024
Q2 | $4.48M | Sell |
102,067
-259,563
| -72% | -$11.4M | 0.4% | 64 |
|
|
2024
Q1 | $15.9M | Sell |
361,630
-281,576
| -44% | -$12.4M | 1.18% | 25 |
|
|
2023
Q4 | $30.5M | Buy |
643,206
+15,000
| +2% | +$712K | 3.39% | 9 |
|
|
2023
Q3 | $27.9M | Sell |
628,206
-145,488
| -19% | -$6.46M | 2.57% | 8 |
|
|
2023
Q2 | $36.9M | Hold |
773,694
| – | – | 4.11% | 6 |
|
|
2023
Q1 | $30.4M | Buy |
773,694
+28,690
| +4% | +$1.13M | 3.15% | 7 |
|
|
2022
Q4 | $21.1M | Buy |
745,004
+60,314
| +9% | +$1.71M | 3.02% | 9 |
|
|
2022
Q3 | $20.6M | Buy |
684,690
+63,925
| +10% | +$1.92M | 2.8% | 13 |
|
|
2022
Q2 | $21.1M | Buy |
620,765
+190,714
| +44% | +$6.47M | 3.29% | 6 |
|
|
2022
Q1 | $19.3M | Sell |
430,051
-19,979
| -4% | -$896K | 2.49% | 9 |
|
|
2021
Q4 | $20.8M | Sell |
450,030
-649
| -0.1% | -$30K | 2.08% | 13 |
|
|
2021
Q3 | $15.1M | Sell |
450,679
-46,500
| -9% | -$1.56M | 2.36% | 14 |
|
|
2021
Q2 | $14.6M | Buy |
497,179
+15,109
| +3% | +$444K | 2.25% | 15 |
|
|
2021
Q1 | $12.4M | Buy |
482,070
+178,072
| +59% | +$4.59M | 2.24% | 10 |
|
|
2020
Q4 | $6.93M | Buy |
303,998
+105,259
| +53% | +$2.4M | 0.91% | 14 |
|
|
2020
Q3 | $4.25M | Sell |
198,739
-13,697
| -6% | -$293K | 2.25% | 16 |
|
|
2020
Q2 | $4.93M | Sell |
212,436
-22,374
| -10% | -$519K | 2.81% | 10 |
|
|
2020
Q1 | $5.01M | Buy |
234,810
+94,058
| +67% | +$2.01M | 5.83% | 5 |
|
|
2019
Q4 | $3.29M | Buy |
+140,752
| New | +$3.29M | 3.17% | 11 |
|